Velcade (subcutaneous and intravenous)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Velcade (subcutaneous and intravenous), covering 2019-11-08 to 2019-11-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of Subcutaneous and Intravenous Velcade in Combination With Dexamethasone in Chinese Subjects With Relapsed and Refractory Multiple Myeloma [Phase 3]